Disparities by race and ethnicity in percutaneous coronary intervention

JAMA Network Open

2025-09-18

(Press-News.org) About The Study: In this cross-sectional study examining racial and ethnic disparities in receipt of percutaneous coronary intervention (PCI) for patients with ST-segment elevation myocardial infarction (STEMI), racial and ethnic disparities persisted throughout the care process. The largest magnitude of disparity was PCI receipt if transferred, but the disparity with the largest impact was PCI receipt when initially presenting to PCI-capable hospitals.

Corresponding Author: To contact the corresponding author, Charleen Hsuan, JD, PhD, email chsuan@psu.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.32660)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.32660?guestAccessKey=1b34668e-afe8-4888-aa3d-dd05b3b83eff&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091825

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Glioblastoma cells “unstick” from their neighbors to become more deadly

2025-09-18

Article Summary: Sylvester researchers used leading-edge technology to study glioblastoma tumors at unprecedented detail. Looking at the locations of individual tumor cell types allowed them to find that “dispersed” glioblastoma cells are more malleable and more aggressive than their “clustered” counterparts. Their findings, corroborated in breast cancer samples as well, point to a possible new general principle of solid tumor biology. MIAMI, FLORIDA (EMBARGOED UNTIL SEPT. ...

Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer

2025-09-18

About The Study: In this cohort study, oral bacteria and fungi were significant risk factors for pancreatic cancer development. Oral microbiota hold promise as biomarkers to identify individuals at high risk of pancreatic cancer, potentially contributing to personalized prevention. Corresponding Authors: To contact the corresponding authors, email Jiyoung Ahn, PhD (jiyoung.ahn@nyulangone.org) and Richard B. Hayes, DDS, PhD (richard.b.hayes@nyulangone.org). To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaoncol.2025.3377) Editor’s ...

New light on toxicity of Bluefin tuna

2025-09-18

Researchers at the ESRF - the European Synchrotron-, together with CNRS, ENS Lyon and the Institute of Marine Research in Norway, have unveiled how Atlantic Bluefin tuna transforms the toxic form of mercury into less harmful forms. Their study, published in Environmental Science & Technology, shows that the tuna’s edible muscle contains not only toxic methylmercury, but also mercury bound in stable, non-toxic compounds. Mercury contamination in seafood is a global health concern. Mercury (Hg) originates both from natural sources like volcanoes ...

Menopause drug reduces hot flashes by more than 70%, international clinical trial finds

2025-09-18

The investigational drug elinzanetant significantly reduces hot flashes and night sweats for post-menopausal women, a large, international clinical trial has found. The OASIS-3 trial enrolled more than 600 postmenopausal women, ages 40 to 65, at 83 sites in North America and Europe. Participants were given either 120 mg of elinzanetant or a harmless placebo daily for 52 weeks. Elinzanetant recipients saw a more than 73% reduction in the frequency and severity of “vasomotor symptoms” – hot ...

FGF21 muscle hormone associated with slow ALS progression and extended survival

2025-09-18

“[…]we have identified FGF21 as a novel biomarker in ALS that is detected in multiple compartments including muscle, spinal cord, and circulation.” BUFFALO, NY — September 18, 2025 — A new research paper was published in Volume 17, Issue 8 of Aging-US on August 9, 2025, titled “The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity.” In this study, led by first author Abhishek Guha and corresponding author Peter H. King from the University ...

Hitting the right note: The healing power of music therapy in the cardiac ICU

2025-09-18

Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking place September 18-20 in Mexico City. Music therapy is the use of music and its elements to reduce stress and improve quality of life. A music therapist uses music therapy as a non-pharmacological and non-invasive intervention to improve a patient's physical, social, communicative, emotional, intellectual, and spiritual ...

Cardiovascular disease risk rises in Mexico, despite improved cholesterol control

2025-09-18

Despite improved statin use and cholesterol control, cardiovascular disease risk rose in Mexico between 2016 and 2023, according to a study being presented at ACC Latin America 2025 that used region-specific tools to more accurately predict the local disease burden. Cardiovascular disease is the leading cause of death in the world, costing billions each year in care. Factors such as socioeconomics, demographics, hypertension, cholesterol, air pollution, obesity and more can play a role in the types of cardiovascular disease (CVD) burden a country or region may be most impacted by. Most models to predict cardiovascular disease risk use data ...

Flexible optical touch sensor simultaneously pinpoints pressure strength and location

2025-09-18

WASHINGTON — Researchers have developed a flexible optical touch sensor that can simultaneously detect the strength and location of pressure with high sensitivity and stability. The advance in tactile sensing paves the way for next-generation robotic touch interfaces, advanced medical diagnostics and highly responsive wearable electronics. “Unlike conventional optical tactile sensors, which tend to have a single input-output path, our sensor design achieves multiple optical channels by embedding polymer ...

Achalasia diagnosis simplified to AI plus X-ray

2025-09-18

Achalasia is a disease caused by impaired movement of the esophagus. Patients experience food getting stuck and regurgitated, as well as chest pain. Currently, upper gastrointestinal endoscopy and high-resolution manometry are commonly used for diagnosis; however, these techniques are invasive. Achalasia has some distinct features that are visible on plain chest X-ray such as twisting or dilation of the esophagus, and fluid retention. However, these signs are vague in most cases, and for this reason, X-rays normally require swallowing barium to diagnose the condition. A research group from Osaka Metropolitan University ...

PolyU scholars pioneer smart and sustainable personal cooling technologies to address global extreme heat

2025-09-18

Global warming poses a growing threat to human health and work performance. Currently, about 3.6 billion people worldwide live in areas highly susceptible to climate change. From 2000 to 2019, more than 480,000 heat-related deaths occurred globally each year. Extreme heat also impairs focus and productivity and worsens mood by elevating stress hormones and disrupting sleep. In response to the increasing frequency of heat waves, The Hong Kong Polytechnic University (PolyU) scholars are developing next-generation personal cooling solutions that push the limits of conventional clothing and promote ...

Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor fo

Disparities by race and ethnicity in percutaneous coronary intervention

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: